Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
28 Nacharam - Mallapur Road, Hyderabad, TG, 500076, IN
Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous administration, can accelerate the launch of novel products, reduce risks, and enhance commercial success.
By: Jeremy Guo
By: Charlie Sternberg
Tambe becomes the first CEO of Biocon Limited following the full integration of Biocon Biologics as its wholly owned subsidiary.
By: Patrick Lavery
New 460,000 sq.-ft. campus will serve as a hub for U.S. Manufacturing Operations.
By: Kristin Brooks
Just – Evotec Biologics will use its validated technology platforms to perform molecular optimization, cell line development, and manufacturing process development for two antibodies.
Collaboration links cell line development and GMP manufacturing to help biotechs reach IND milestones faster.
By: Tim Wright
The CDMO says the technology simplifies downstream processing for complex biologics.
Forge Biologics will provide process development and manufacturing services to support gene therapy for ultrarare disease.
A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
By: Adam Tuszyner
The independent assurance provider Det Norske Veritas conducted the validation.
Authorization clears the way for customers to enter Brazil’s $40 billion pharmaceutical market.
Will accelerate development and manufacturing of the innovative bispecific antibody for potential treatment of IBD.
The company will be focused on immune cell-targeting biologics and molecular glue payload-enabled antibody-drug conjugates.
The expansion adds state-of-the-art upstream and downstream GMP processing capabilities.
Released By Bora Biologics
Suitable for storing and administering highly sensitive biologics, including cell and gene therapies, biosimilars, and emergency medications.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
